[Pe-033] English Poster Session 033「Neuroimmunology: NMOSD 2」

Thu. May 30, 2024 5:45 PM - 7:05 PM Poster (Hall E, E Block, B2F, TIF)

Chair(s): Kazumasa Yokoyama (Tohsei center for neurological diseases, Japan), Masaru Matsui (Otsu Red Cross Hospital, Japan)

+Add all to schedule

[Pe-033-1] Efficacy of Eculizumab in Acute Phase of Neuromyelitis Optica Spectrum Disorder: A Case Series Study [Encore Presentation]

Mitsuru Watanabe¹, Katsuhisa Masaki¹, Eizo Tanaka¹, Takuya Matsushita^1,2, Noriko Isobe¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurology, Kochi Medical School, Kochi University, Japan)

[Pe-033-2] Biopharmaceuticals on preventing the recurrence of neuromyelitis optica spectrum disorder

Yoshio Sakiyama, Kazuki Fujita, Michiko Tsutsumiuchi (Dept.Neurology, Jichi Med Univ, Saitama MC, Japan)

Cancelled

[Pe-033-3] withdrawn

[Pe-033-4] Long-term safety and effectiveness of eculizumab in AQP4+ neuromyelitis optica spectrum disorder [Encore Presentation]

Jin Nakahara¹, Ichiro Nakashima², Hiroaki Yokote³, Yasuhiro Manabe⁴, Kazumi Okamura⁵, Kou Hasegawa⁵, Kazuo Fujihara^6,7
(1.Keio University School of Medicine, Japan, 2.Tohoku Medical and Pharmaceutical University, Japan, 3.Tokyo Metropolitan Komagome Hospital, Japan, 4.Okayama Central Hospital, Japan, 5.Alexion Pharma GK, Japan, 6.Fukushima Medical University, Japan, 7.Southern TOHOKU Research Institute for Neuroscience (STRINS), Japan
)